Evidence map›Paper›PMID 36895677›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2023

Lessons learned from the implementation of integrated serosurveillance of communicable diseases in the Americas.

Martha-Idalí Saboyá-Díaz, Luis Gerardo Castellanos, Ana Morice, Maria Paz Ade, Gloria Rey-Benito, Gretchen M Cooley, Heather M Scobie, Ryan E Wiegand, Melissa M Coughlin, Diana L Martin

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Integrated serosurveillance of multiple communicable diseases in the hinterland of Guyana.Revista panamericana de salud publica = Pan American journal of public health · 2026
    Article
  5. Article
  6. Integrated serological surveillance of communicable diseases in the Paraguayan Chaco, 2019.Revista panamericana de salud publica = Pan American journal of public health · 2025
    Article
  7. Article
  8. Monitoring of Leishmania transmission in the postelimination phase: The potential of serological surveys.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
  9. Article
  10. Article
  11. PAHO/WHO Collaborating Centers: celebrating the achievement of our common goals.Revista panamericana de salud publica = Pan American journal of public health · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Martha-Idalí Saboyá-DíazPan American Health Organization Washington, D.C. United States of America Pan American Health Organization, Washington, D.C., United States of America.
Luis Gerardo CastellanosPan American Health Organization Washington, D.C. United States of America Pan American Health Organization, Washington, D.C., United States of America.
Ana MoricePan American Health Organization Washington, D.C. United States of America Pan American Health Organization, Washington, D.C., United States of America.
Maria Paz AdePan American Health Organization Washington, D.C. United States of America Pan American Health Organization, Washington, D.C., United States of America.
Gloria Rey-BenitoPan American Health Organization Washington, D.C. United States of America Pan American Health Organization, Washington, D.C., United States of America.
Gretchen M CooleyCenters for Disease Control and Prevention Atlanta United States of America Centers for Disease Control and Prevention, Atlanta, United States of America.
Heather M ScobieCenters for Disease Control and Prevention Atlanta United States of America Centers for Disease Control and Prevention, Atlanta, United States of America.
Ryan E WiegandCenters for Disease Control and Prevention Atlanta United States of America Centers for Disease Control and Prevention, Atlanta, United States of America.
Melissa M CoughlinCenters for Disease Control and Prevention Atlanta United States of America Centers for Disease Control and Prevention, Atlanta, United States of America.
Diana L MartinCenters for Disease Control and Prevention Atlanta United States of America Centers for Disease Control and Prevention, Atlanta, United States of America.
Centers for Disease Control and Prevention · USWorld Health Organization Regional Office for the Americas · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Systematize the experience and identify challenges and lessons learned in the implementation of an initiative for integrated serosurveillance of communicable diseases using a multiplex bead assay in countries of the Americas. Methods: Documents produced in the initiative were compiled and reviewed. These included concept notes, internal working papers, regional meetings reports, and survey protocols from the three participating countries (Mexico, Paraguay, and Brazil) and two additional countries (Guyana and Guatemala) where serology for several communicable diseases was included in neglected tropical diseases surveys. Information was extracted and summarized to describe the experience and the most relevant challenges and lessons learned. Results: Implementing integrated serosurveys requires interprogrammatic and interdisciplinary work teams for the design of survey protocols to respond to key programmatic questions aligned to the needs of the countries. Valid laboratory results are critical and rely on the standardized installment and roll-out of laboratory techniques. Field teams require adequate training and supervision to properly implement survey procedures. The analysis and interpretation of serosurveys results should be antigen-specific, contextualizing the responses for each disease, and triangulated with programmatic and epidemiological data for making decisions tailored to specific population socioeconomic and ecologic contexts. Conclusions: Integrated serosurveillance as a complementary tool for functional epidemiological surveillance systems is feasible to use and key components should be considered: political engagement, technical engagement, and integrated planning. Aspects such as designing the protocol, selecting target populations and diseases, laboratory capacities, anticipating the capacities to analyze and interpret complex data, and how to use it are key.

Indexed as

Americascommunicable diseasesSerologysurveillance

Identifiers

PMID36895677
PMCPMC9989549
OpenAlexW4323364554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.